Premier Path Wealth Partners, LLC Abb Vie Inc. Transaction History
Premier Path Wealth Partners, LLC
- $656 Billion
- Q4 2024
A detailed history of Premier Path Wealth Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Premier Path Wealth Partners, LLC holds 10,426 shares of ABBV stock, worth $2.01 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
10,426
Previous 9,073
14.91%
Holding current value
$2.01 Million
Previous $1.79 Billion
3.4%
% of portfolio
0.28%
Previous 0.28%
Shares
5 transactions
Others Institutions Holding ABBV
# of Institutions
4,064Shares Held
1.28BCall Options Held
17.8MPut Options Held
15.7M-
Vanguard Group Inc Valley Forge, PA173MShares$33.4 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.3 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$15.4 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$9.98 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$7.65 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $341B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...